Share

October 2014; 4 (5) Five New Things

Blood pressure management in stroke

Five new things

Ritvij Bowry, Digvijaya D. Navalkele, Nicole R. Gonzales
First published October 13, 2014, DOI: https://doi.org/10.1212/CPJ.0000000000000085
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
19199

Share

Article Information

vol. 4 no. 5 419-426
DOI: 
https://doi.org/10.1212/CPJ.0000000000000085
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published October 13, 2014.
Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Ritvij Bowry, MD,
    2. Digvijaya D. Navalkele, MD, MPH and
    3. Nicole R. Gonzales, MD
  1. Ritvij Bowry, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Digvijaya D. Navalkele, MD, MPH and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Nicole R. Gonzales, MD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. editorial board member of Stroke

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH Grants 1U01NS069763-01 and R01 NS038384 and is the local site PI at UT Health for the Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST). Carotid Revascularization Endarterectomy vs. Stenting Trial (CREST) Ethnic/Racial Variation in Intracerebral Hemorrhage (ERICH)NINDS 1U01NS069763-01, local site PI ; Futility Study of Deferoxamine Mesylate in Intracerebral Hemorrhage (HI-DEF Trial)U01 NS074425, NIH/NINDS; local site PI

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. University of Texas Health Sciences Center at Houston.
  1. Correspondence to:
    Ritvij.Bowry{at}uth.tmc.edu
View Full Text

Article usage

Article usage: October 2014 to July 2022

AbstractFullPdfSource
Oct 20141527119191Highwire
Nov 201415901952813Highwire
Dec 20143311839Highwire
Jan 20153591422Highwire
Feb 2015222625Highwire
Mar 2015233827Highwire
Apr 20153561354Highwire
May 20152071324Highwire
Jun 201519566Highwire
Jul 201514269Highwire
Aug 201513739Highwire
Sep 2015147816Highwire
Oct 201515218Highwire
Oct 201502919pmc
Nov 201512412Highwire
Nov 201501513pmc
Dec 201515121Highwire
Dec 201501411pmc
Jan 201615145Highwire
Jan 20160379pmc
Feb 20169958Highwire
Feb 20160167pmc
Mar 20168475Highwire
Mar 201603017pmc
Apr 20166353Highwire
Apr 201602511pmc
May 20167611Highwire
May 201601710pmc
Jun 201679348Highwire
Jun 201603615pmc
Jul 20168141Highwire
Jul 20160336pmc
Aug 20168654Highwire
Aug 201606811pmc
Sep 20166802Highwire
Sep 201606717pmc
Oct 20168305Highwire
Oct 2016026623pmc
Nov 20166602Highwire
Nov 2016021337pmc
Dec 20169035Highwire
Dec 2016031545pmc
Jan 20177114Highwire
Jan 2017052649pmc
Feb 20175104Highwire
Feb 2017051125pmc
Mar 20179913Highwire
Mar 2017082960pmc
Apr 20177214Highwire
Apr 201768889969pmc
May 20176501Highwire
May 2017618841005pmc
Jun 20175203Highwire
Jun 2017579681093pmc
Jul 20174713Highwire
Jul 20175910321149pmc
Aug 20174701Highwire
Aug 201710511371297pmc
Sep 20174100Highwire
Sep 201713015551755pmc
Oct 20176101Highwire
Oct 201710218512127pmc
Nov 20178220Highwire
Nov 201714917662008pmc
Dec 20173800Highwire
Jan 20184090Highwire
Feb 201862141Highwire
Mar 20188732Highwire
Apr 20187444Highwire
Apr 201811418282055pmc
May 20186122Highwire
Jun 20186102Highwire
Jun 20187915461776pmc
Jul 20184600Highwire
Aug 20185710Highwire
Aug 20188319502208pmc
Sep 20184910Highwire
Oct 20185210Highwire
Nov 20188052Highwire
Dec 20183600Highwire
Jan 20197010Highwire
Feb 20197212Highwire
Mar 20197820Highwire
Apr 20196711Highwire
May 20194120Highwire
Jun 20193610Highwire
Jul 20193820Highwire
Aug 20194400Highwire
Sep 20192310Highwire
Oct 20193221Highwire
Nov 20193341Highwire
Dec 20195442Highwire
Jan 20208010Highwire
Feb 20203020Highwire
Mar 20201921Highwire
Apr 20207721Highwire
May 202013953Highwire
Jun 20206075Highwire
Jul 20207110Highwire
Aug 20204422Highwire
Sep 20206450Highwire
Oct 202013311Highwire
Nov 20206611Highwire
Dec 20208831Highwire
Jan 20216030Highwire
Feb 20217162Highwire
Mar 20216610Highwire
Apr 20215932Highwire
May 20216500Highwire
Jun 20215520Highwire
Jul 20214500Highwire
Aug 20217640Highwire
Sep 20217502Highwire
Oct 20218231Highwire
Nov 20218610Highwire
Dec 20216422Highwire
Jan 20225211Highwire
Feb 202210772Highwire
Mar 20226820Highwire
Apr 20224211Highwire
May 20227224Highwire
Jun 20226100Highwire
Jul 20224501Highwire

The Nerve!: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me